The Brain Science Foundation, situated within the Institute for the Neurosciences at Brigham and Women’s Hospital, seeds novel and results-oriented research of meningioma and other primary brain tumors and seeks to advance understanding of brain function as it relates to these tumors.
More than 370,000 people in the United States are living with a primary brain tumor, a number that continues to increase, particularly among older Americans. Brain tumors are the second leading cause of cancer-related deaths among children. Despite improvements in the diagnosis and management of brain tumors, prognosis for many with the disease is relatively poor.
Grants are typically awarded for two years at $50,000 to $75,000 per year. Preference will be given to new grants and to applicants who have not already received three or more years of BSF support for an ongoing initiative. In keeping with the mission and strategic goals of the Institute for the Neurosciences, support will be directed toward projects focused on biomarker development such as imaging, genetics, and fluid (proteomics, metabolomics, immune); novel targeted therapies including neuroprotection, neural repair, neuromodulation, and neuroinflammation; and interdisciplinary, translational approaches.